Evidence map›Paper›PMID 32412411›Full record

ArticleeLife2020

Stimulation strength controls the rate of initiation but not the molecular organisation of TCR-induced signalling.

Claire Y Ma, John C Marioni, Gillian M Griffiths, Arianne C Richard

Open access · goldAbstract readComparative Study
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Antigen perception in T cells by long-term Erk and NFAT signaling dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Proofreading does not result in more reliable ligand discrimination in receptor signaling due to its inherent stochasticity.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Human CD8Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Claire Y MaCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-4244-7535
John C Marioni *Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-9092-0852
Gillian M Griffiths *Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-0434-5842
Arianne C Richard *Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-8708-9997
University of Cambridge · GBEuropean Bioinformatics Institute · GB

Funding

Cancer Research UK 22231Cancer Research UK A17197Medical Research Council MR/M008975/1Medical Research Council MR/P014178/1Wellcome TrustWellcome Trust 100140Wellcome Trust 103930Wellcome Trust 217100
6 · The paper itself

Abstract

Millions of naïve T cells with different TCRs may interact with a peptide-MHC ligand, but very few will activate. Remarkably, this fine control is orchestrated using a limited set of intracellular machinery. It remains unclear whether changes in stimulation strength alter the programme of signalling events leading to T cell activation. Using mass cytometry to simultaneously measure multiple signalling pathways during activation of murine CD8

Indexed as

AnimalsCD8-Positive T-LymphocytesCells, CulturedFemaleFlow CytometryInterferon Regulatory Factor-8Interferon Regulatory FactorsKineticsLigandsLymphocyte ActivationMaleMice, Inbred C57BLMice, TransgenicNuclear Receptor Subfamily 4, Group A, Member 1OvalbuminPeptide FragmentsInterferon Regulatory Factor-8Interferon Regulatory FactorsLigandsNr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1OVA-8OvalbuminPeptide FragmentsReceptors, Antigen, T-CellRibosomal Protein S6CD8 T cellscomputational biologyimmunologyinflammationmass cytometrymousesignallingsystems biologyT cell receptor

Identifiers

PMID32412411
PMCPMC7308083
OpenAlexW3025291099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.